Facts and figures
In 2016 the HOCHDORF Group worked on the implementation of strategy 2016 – 2020. Important elements of this include forward integration and the development and marketing of new high added-value products. With the majority holding in Pharmalys Laboratories SA, HOCHDORF took an important step towards the successful implementation of the strategy. Earnings in 2016 reached record figures thanks to the measures initiated earlier.
The HOCHDORF Group
The HOCHDORF Group, which was founded in 1895 and has its headquarters in Hochdorf (near Lucerne) maintains two milk plants in Switzerland and one milk plant in both Lithuania and Germany (60 % stake). In addition, high-quality infant formula is produced at the Swiss milk plants. Furthermore, HOCHDORF has a cereal plant in Switzerland (processing wheat germ) and an oil mill in Germany. As of the end of 2016, HOCHDORF has a 51 % majority holding in the Pharmalys Group. Pharmalys sells infant formula among other things, under the brands Primalac and Swisslac, in over 40 countries. HOCHDORF is among the leading food companies in Switzerland and at 31 December 2016 had more than 630 employees worldwide. HOCHDORF products contribute towards health and well-being, from babies to senior citizens. The products are sold to the food industry and to the wholesale and retail trade in over 90 countries.
Our strategic objective
The HOCHDORF Group is an independent global company operating in the business areas Dairy Ingredients, Baby Care and Cereals & Ingredients. As a Swiss food company we are guided by the Swiss values of «reliability», «quality» and «precision». As a company operating in niche markets, it is HOCHDORF’s aim to keep the agility of a medium-sized company and conquer new markets by showing the necessary courage. The HOCHDORF Group focuses its products on premium markets and offers its customers a correspondingly high standard of service. In the medium term, HOCHDORF is aiming for growth by offering products with high added value such as top quality milk derivatives, infant formula and healthy children’s foods. To improve its earnings figures HOCHDORF is aiming for forward integration in terms of both sales and products.
Key indicators in the annual report
|Processed milk and whey in tonnes||741,769||761,240||506,963||455,647|
|Products sold in tonnes||237,054||242,821||99,155||91,699|
|Total assets (in CHF 1,000)||425,474||340,396||331,109||243,485|
|Equity ratio||10.80 %||56.60 %||43.20 %||42.60 %|
|Cash flow from operating activities (in CHF 1,000)|| |
|Market capitalisation (in CHF 1,000)||444,417||242,044||147,787||93,600|
|Share price at 31.12. in CHF||309.75||168.70||138.00||104.00|
|Earnings per share in CHF||14.12||11.73||17.45||6.95|
|Staffing levels at 31.12.||633||625||573||362|